So whats the real difference, and which option might work better for you
Listed Products of GLP-1 Receptor Agonists (GLP-1RA) At present, 9 GLP-1 receptor agonist hypoglycemic drugs have been approved for marketing in the world, namely: exenatide, liraglutide, Exenatide extended-release (exenatide ER), albiglutide, dulaglutide , lixisenatide, benaglutide, semaglutide, polyethylene glycol loxenatide injection and oral semaglutide
Alternatively, adding 4mL creates a 5,000 mcg/mL concentration for those who prefer larger injection volumes or easier titration between doses
And as long as it's continued to completion, I don't think efficacy is really a question at this point either. However, lower dosing often means a longer treatment course
Cardiometabolic Research Beyond weight reduction, retatrutide's glucagon receptor component has attracted research interest for its cardiovascular effects
Where is the best place on the body to inject semaglutide GLP-1